Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used as analgesic or antipyretic agents for the clinical treatment of inflammatory diseases such as arthritis, lumbago and rheumatism. These NSAIDs (e.g., ibuprofen, aspirin, and indomethacin) exhibit an inhibitory action on the cyclooxygenase (COX) that catalyzes the biosynthesis of prostaglandins and thromboxane from arachidonic acid. There are two isoforms of the membrane-bound COXs, COX-1 expressed constitutively, and COX-2 induced by stimuli of cytokines, mitogens or hormones. The constitutive COX-1 has also been reported to be induced by the stimulus of an angiogenic cytokine vascular endothelial growth factor (VEGF) 1) or by shear stress in vascular endothelial cells.
Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used as analgesic or antipyretic agents for the clinical treatment of inflammatory diseases such as arthritis, lumbago and rheumatism. These NSAIDs (e.g., ibuprofen, aspirin, and indomethacin) exhibit an inhibitory action on the cyclooxygenase (COX) that catalyzes the biosynthesis of prostaglandins and thromboxane from arachidonic acid. There are two isoforms of the membrane-bound COXs, COX-1 expressed constitutively, and COX-2 induced by stimuli of cytokines, mitogens or hormones. The constitutive COX-1 has also been reported to be induced by the stimulus of an angiogenic cytokine vascular endothelial growth factor (VEGF) 1) or by shear stress in vascular endothelial cells. 2) Recently, several COX-2 selective inhibitors such as meloxicam 3) and celecoxib 4) have been developed as NSAIDs because these substances show little gastropathy, a typical side effect of NSAIDs.
We have previously reported the synthesis of a number of novel oximes and their derivatives, with several compounds showing anti-inflammatory activities in carrageenan-induced rat foot-pad swelling assay and histamine-induced rat vascular permeability assay. 5, 6) We also reported the COX-1 inhibitory effect of the 4Ј-piperidinoacetophenone oxime (POx), 4Ј-morpholinoacetophenone oxime (M-Ox) and their Oacetyl derivatives (P-Ox-Ac or M-Ox-Ac). 6) The metabolic products of arachidonic acid catalyzed by 5-lipoxygenase (LOX) are leukotrienes (LTs) which function as important mediators in many types of inflammation reaction including allergy, asthma, and arthritis. For instance, LTC 4 and LTD 4 , well-known components of the slow-reacting substance of anaphylaxis (SRS-A), induce severe bronchoconstriction and increase vascular permeability, and LTB 4 causes leukocyte chemotaxis. [7] [8] [9] [10] Therefore, the development of dual inhibitors of COX and 5-LOX should be promising for the treatment of several inflammatory and allergy symptoms. Many investigations have shown that the enzymes catalyzing the arachidonic acid cascade (COX, 5-LOX, and/or 12-LOX) were inhibited by various hydroxamic acids and their derivatives. [11] [12] [13] [14] Kramer et al. have reported a dual inhibitory action to COX and 5-LOX by hydroxylamine analogs of 2, 6 di-tert-butylphenols. 15) The purpose of the present study is to search more effective anti-inflammatory or anti-allergic drugs such as COX-2 selective and/or 5-LOX inhibitors. Hydroxylamine derivatives, which are substances reduced from anti-inflammatory oximes, are potential candidates for both anti-inflammatory and anti-allergic agents. Thus, anti-inflammatory oximes (POx and M-Ox) were reduced to the corresponding hydroxylamines; (1-hydroxylamino-1-(4Ј-piperidinophenyl) ethane, P-HA, and 1-hydroxylamino-1-(4Ј-morpholinophenyl) ethane, M-HA). 16, 17) We also prepared N,O-diacetyl hydroxylamine derivatives, i.e., 1-(N,O-diacetyl hydroxylamino)-1-(4Ј-piperidinophenyl) ethane (P-HA-Ac) and 1-(N,O-diacetyl hydroxylamino)-1-(4Ј-morpholinophenyl) ethane (M-HA-Ac), as O-acetyl oximes inhibited the increased vascular permeability induced by histamine in rat skin more strongly than the original oximes. 6) Anti-inflammatory activities were evaluated by screening with carrageenan-induced mouse foot-pad swelling assay. 18) Anti-allergic activities (type I) were examined by the abdominal wall (AW) method assay with a simple technique for induction and estimation of mouse anaphylactic reaction to ovalbumin (OVA). 19, 20) Anti-allergic activities (type IV) were tested by the 2,4-dinitrofluoro benzene (DNFB)-induced con- The anti-inflammatory activities of several novel oximes and O-acyl oximes that we synthesized have been reported based on carrageenan-induced rat foot-pad swelling assay and histamine-induced rat vascular permeability assay. A cyclooxygenase (COX)-1 inhibitory effect has also been reported for 4-piperidinoacetophenone tact hypersensitivity reaction. 21) Furthermore, in vitro COX and 5-LOX inhibitory tests for the hydroxylamines and related compounds were performed to elucidate the mechanism of their inhibitory effect on inflammation and allergy.
MATERIALS AND METHODS

Animals
Male ddY mice (SPF, 5 weeks old for type I anti-allergic effect assay and 6 weeks old for anti-inflammatory assay), male BALB/c mice (SPF, 7-8 weeks old for type IV anti-allergic effect assay), and male Sprague-Dawley rats (SPF, 120-150 g body weight) were purchased from Japan SLC Co. (Hamamatsu). These animals were maintained under constant temperature (24Ϯ2°C) and were given commercial laboratory diet (CE-2, Clea Japan, Tokyo) and tap water ad libitum. This animal study was approved by the Experimental Animal Research Committee of the School of Pharmaceutical Sciences, Mukogawa Women's University.
Reagents The following reagents were used: sodium cyanoborohydride (NaBH 3 CN) (Aldrich Chemical, Co., Inc., U.S.A.); acetyl chloride (CH 3 COCl), DNFB, sodium carboxymethyl cellulose (CMC · Na), dimethyl sulfoxide (DMSO), ibuprofen, and diphenhydramine hydrochloride (Nacalai Tesque, Inc., Osaka, Japan); hydroxylamine hydrochloride (NH 2 OH · HCl), Evans blue, and phenidone (Wako Pure Chemical Industries, Ltd., Osaka, Japan); olive oil (Japanese Pharmacopoeia grade, Maruishi, Pharmaceutical, Co., Japan); Freund's incomplete adjuvant (FIA) (Difco Laboratories, Detroit, MI, U.S.A.); OVA (Sigma Chem. Co., St. Louis, U.S.A.); NS-398 (Cayman Chemical, Co., U.S.A.). l-Carrageenan was purchased from two manufacturers, Zushikagaku Laboratory, Inc., Kanagawa for the mouse assay and Sigma Chem. Co., U.S.A. for the rat assay. All other reagents and solvents used were of the highest grade of commercial products available. COX (ovine) inhibitor screening assay kit (Catalog No. 560101), LOX inhibitor screening assay kit (Catalog No. 760700), and arachidonate 5-LOX (potato) (Catalog No. 60400; Lot No. 15743; Activity, 9750 units/ml) were purchased from Cayman Chemical, Co., U.S.A.
Apparatus Melting points were measured with a Yanaco MP-S3 apparatus and are uncorrected. Infrared (IR) spectra were recorded on a Perkin Elmer FT-IR spectrometer Spectrum 2000. Electron impact mass spectrometry (EI-MS) was done with a JEOL JMS-DX 303 spectrometer by a direct inlet system at 70 eV.
1 H-and 13 C-NMR spectra were measured on a JEOL JNM-ECP 400 spectrometer in chloroform-d at 50°C using tetramethylsilane (TMS) as an internal standard. All signal assignments on 1 H-and 13 C-NMR spectra were conformed by 1 H-detected heteronuclear multiple quantum coherence (HMQC), heteronuclear multiple bond coherence (HMBC) and nuclear overhauser effect (NOE) experiments.
Preparation of Hydroxylamine Compounds Hydroxylamines (P-HA and M-HA) were prepared from the P-Ox or M-Ox reported previously, 5) according to a method using NaBH 3 CN described by Borch et al. with some modifications. 22) The detailed preparation method and the MS, IR, and NMR spectrometric and elemental analysis data of their compounds have been reported elsewhere. 16, 17) Preparation of N,O-Diacetyl Hydroxylamine Compounds (P-HA-Ac or M-HA-Ac) A solution of CH 3 COCl (2.5 eq) in anhydrous CHCl 3 was added dropwise to a mixture of the hydroxylamine (P-HA or M-HA) (1 eq), triethylamine (2.5 eq), and anhydrous CHCl 3 under ice-cooling. The solution was washed with 10% NaHCO 3 Inhibitory Effect on Carrageenan-Induced Foot-Pad Swelling in Mice All test compounds and ibuprofen were prepared by suspending them in 0.5% CMC · Na solution, immediately before the start of the experiments. Mice were starved overnight before the experiment, and then administered orally with the CMC · Na suspension of the test compounds (150 mg/15 ml/kg or 37.5 mg/15 ml/kg). Control experiments were performed with the 0.5% CMC · Na suspension of distilled water alone (15 ml/kg). After 30 min, 0.02 ml of a 1% l-carrageenan suspension in sterile saline was injected into the right hind paw (foot-pad) of mice and the left foot-pad of mice was injected with sterile saline alone (0.02 ml). The thickness of the foot-pads on both sides was measured with a Peacock Dial Thickness Gauge (Ozaki, Japan), before and at 1, 2, 3, 4, 5, 6, and 7 h after carrageenan injection, and the differences in the thickness were calculated. The degree of foot-pad swelling was expressed as follows:
increase in foot-pad thickness (mm)ϭ(RtϪRo)Ϫ (LtϪLo) where Rt: right foot-pad thickness after carrageenan injection, Ro: right foot-pad thickness before carrageenan injection, Lt: left foot-pad thickness after saline injection, Lo: left foot-pad thickness before saline injection.
Inhibitory Effect on Carrageenan-Induced Foot-Pad Swelling in Rats Inhibitory assay of P-HA on carrageenan-induced foot-pad swelling in rats was carried out using the same conditions as previously described. 5, 6) Differences between the experiments using rat and mouse were as follows. Swelling reactions of rats were produced in the right foot-pad by subplantar injection of 0.1 ml of a 1% l-carrageenan suspension in sterile saline. The dose of P-HA tested was 75 mg/kg or 30 mg/kg of body weight, respectively. From the rat data, we expressed the % swelling as well as the data from a previous report. 5, 6) Inhibitory Effect on Anaphylactic Reaction (AW Method) The experiments were carried out according to a method reported previously. 19, 20) Briefly, mice were sensitized intraperitoneally with a 1 : 1 emulsion of OVA (2 mg/ml of saline) and FIA. CMC · Na suspension (0.5%) of the test compounds (150 mg/15 ml/kg) were administered orally to mice which were starved overnight before the challenge, 14 d after the sensitization of OVA. Control mice were administered 0.5% CMC · Na suspension of distilled water alone (15 ml/kg). In the case of diphenhydramine hydrochloride, mice of the experimental group were orally administered the drug dissolved in distilled water and control mice were given water only. Thirty minutes after the oral administration, 0.1 ml of 1% Evans blue dye was injected intravenously, and the animals were anesthetized with diethyl ether. The skin of the abdomen was detached, and 5 min after injection of the dye, OVA solution (5 mg/0.05 ml/site, 0.1 mg/ml of saline) was injected in the exposed abdominal wall. The mouse was killed by cervical dislocation 7 min after the challenge, and after removal of the abdominal wall, the diameter of the blue area of the abdominal wall was measured. This anti-allergic activity (type I) was expressed as the percentage inhibition compared with the control group.
Inhibitory Effect on DNFB-Induced CHR The dorsal skin of the mice was shaved on the day before the experiment, and the mice were sensitized with 0.1 ml of 0.5% DNFB in acetone-olive oil (4 : 1) applied to the dorsal skin on days Ϫ1 and 0. Five days after the second sensitization, mice were dosed percutaneously with ethanol-acetone-olive oil (5 : 4 : 1) solution of the test compounds (0.5 or 0.1 mg/0.02 ml/ear) or phenidone (1 or 0.5 mg/0.02 ml/ear) on both right and left ears. As controls, both ears of the mice were painted with the vehicle used for the dissolution of the test compounds (0.02 ml/ear). Immediately after the above percutaneous administration, the mice were challenged on the right ear with 0.5% DNFB in acetone-olive oil (4 : 1) (0.02 ml/ear) and the left ear was painted with the vehicle, acetone-olive oil (4 : 1) alone (0.02 ml/ear).
Ear thickness was measured with a Peacock Dial Thickness Gauge before and 24 h after the DNFB challenge, and the swelling percentage (%) was calculated. The degree of ear swelling was expressed as follows:
where Eo and Et represent the ear thickness before and after challenge.
Inhibitory Assays of COX-1, COX-2 and 5-LOX Screening for COX-1 and COX-2 inhibitors was performed using a COX (ovine) inhibitor screening assay kit according to the manufacturer's instructions.
Preliminary screening assay for the 5-LOX inhibitor was performed using a LOX inhibitor screening assay kit for 15-LOX, with modifications. Briefly, immediately before a test, an assay buffer solution of 3-fold dilution of 5-LOX (potato) purified with an ultrafiltration membrane (30 KDa cut off) was used instead of the 15-LOX packed as the standard enzyme. Test compounds dissolved in DMSO were added to each assay buffer, and the final solvent used for the preparation of the samples was used as a positive control. The IC 50 value, the concentration necessary to obtain 50% inhibition of the responses, was determined from the logarithmic regression line of a dose-response curve.
Statistical Analysis The data from the inhibitory tests of carrageenan-induced swelling and DNFB-induced CHR were analyzed using Williams' multiple comparison test. The data from the inhibitory test of the anaphylactic reaction were examined using analysis of variance followed by Fisher's Protected Least Significant Difference (PLSD) test. Each value represents the meanϮS.E. Asterisks indicate significant differences from the control group (**, pϽ0.01 and *, pϽ0.05).
RESULTS AND DISCUSSION
The structures and abbreviations of the compounds used in this study are shown in Table 1 . These hydroxylamines and diacetyl hydroxylamines were used as racemic compounds. In the present study, the assay of the inhibitory effect on carrageenan-induced foot-pad swelling using the mouse model 18) was conducted to evaluate the in vivo anti-inflammatory effects because the total doses of the necessary test compounds in the mouse model were smaller than those in the rat model, although it has been reported that the susceptibility to the anti-inflammatory test by NSAIDs in carrageenan-induced foot-pad swelling using the mouse model is lower than that of rats. 23) To confirm whether the foot-pad swelling response in mouse is induced by carrageenan and the swelling can be inhibited by NSAIDs, we conducted the following experiments. The level of the foot-pad swelling response of the mice to the l-carrageenan (Sigma Chem. Co.), which was used previously for rats 6) was low, however, we obtained satisfactory results by using another l-carrageenan purchased from Zushikagaku Laboratory Inc. At 5 to 6 h after its injection, the increase in thickness of mouse footpad reached maximal level. This carrageenan-induced footpad swelling in mice could be inhibited by ibuprofen used as a reference drug, and maximum inhibition was observed 5 h after carrageenan injection (25 mg/kg, per os; percentage inhibition of foot-pad swelling compared with the vehicletreated control group at 5 h, 28.81Ϯ6.59, pϽ0.05).
The time course of the foot-pad swelling response in mice of P-HA (150 and 37.5 mg/kg, per os) is presented in Fig. 1a . The inhibitory effects of carrageenan-induced foot-pad swelling in rats of P-HA (75 mg/kg and 30 mg/kg, per os) are also shown in Fig. 1b to confirm whether the method using mouse in this study could give results consistent with the previous method using rat. The results show that P-HA displays concentration-dependent inhibition activity on the carrageenan-induced foot-pad swelling in both mice and rats. The swelling reaction in mice was markedly inhibited by P-HA at 4 to 6 h after carrageenan injection and the inhibitory activity in rats began from immediately after carrageenan in-jection. Thus, although the inhibitory patterns differ in mouse and rat, the inhibitory effect of the swelling reaction between the two animals showed the same tendency. Figure 2 shows the anti-inflammatory activities (% of inhibition) of the hydroxylamines and N,O-diacetyl hydroxylamines 5 h after carrageenan injection. All tested compounds clearly inhibited carrageenan-induced foot-pad swelling in mice. Interestingly, P-HA derived from P-OX potently inhibited the carrageenan-induced foot-pad swelling reaction although the original P-OX 5) had no inhibitory effect on the reaction. The Fig. 1 . Time Course of Anti-inflammatory Activity of P-HA on Carrageenan-Induced Foot-Pad Swelling in Mice (a) and Rats (b) (a) P-HA (150 or 37.5 mg/kg) was given orally 0.5 h before the injection of 1% l-carrageenan (0.02 ml) in mice. Control group mice were administered 0.5% CMC · Na suspension of distilled water alone (15 ml/kg). Each symbol and bar of foot-pad thickness (mm) increase represent the meanϮS.E. for 5-6 mice. (b) P-HA (75 or 30 mg/kg) was given orally 0.5 h before the injection of 1% l-carrageenan (0.1 ml) in rats. Control group rats were administered 0.5% CMC · Na suspension of distilled water alone (15 ml/kg). Each symbol and bar of the swelling percentage (%) represent the meanϮS.E. for 5 rats. Statistical analyses were performed by Williams' multiple comparison test. Asterisks indicate significant differences from the control group (**, pϽ0.01; *, pϽ0.05). See text for further details.
anti-inflammatory activity of P-OX was estimated by the inhibitory effect on increased vascular permeability induced by histamine.
6)
The AW method is one of the simplest techniques for inducing and detecting anaphylactic reaction in in vivo models. 19, 20) As shown in Fig. 3 , oral administration of P-HA-Ac significantly decreased the diameter of the blue spot compared with the control groups. Also, the anti-allergic effect of 150 mg/kg body weight of P-HA-Ac was nearly the same as that of the 5 mg/kg body weight of diphenhydramine hydrochloride which has been widely used against allergic disorders as a histamine H 1 -receptor antagonist.
P-HA and M-HA showed significant inhibitory effects on DNFB-induced CHR (type IV) in mice after percutaneous administration at a dose of 0.5 and 0.1 mg/ear, respectively (Fig. 4) . These hydroxylamines showed higher inhibitory activity than the COX/5-LOX inhibitor phenidone, which was used as a reference agent, because phenidone showed a significant inhibitory effect at the dose of 1 mg/ear, but not at a dose of 0.5 mg/ear (1 mg/ear; percentage inhibition of ear swelling compared with the vehicle-applied control group at 24 h, 49.1Ϯ14.7, pϽ0.01). COX-1 and COX-2 enzyme inhibitory activities of the hydroxylamines and N,O-diacetyl hydroxylamines and reference drug and agent are shown in Table 2 . All tested compounds clearly inhibited both COX-1 and COX-2 activity and Mice were sensitized intraperitoneally (50 mg/50 ml/mouse) with ovalbumin (OVA) in Freund's incomplete adjuvant on day 0. On day 14, 0.5% CMC · Na suspension of test compounds (150 mg/kg) were administered orally 0.5 h prior to challenge on the abdominal wall with OVA (5 mg/50 ml/site). Control group mice were administered 0.5% CMC · Na suspension of distilled water alone (15 ml/kg). Diphenhydramine hydrochloride (5 mg/kg) was used as a reference compound. Each column and bar of the percentage inhibition (%) represent the meanϮS.E. for 8 mice. Statistical analyses were performed by analysis of variance, followed by Fisher's PLSD test. Asterisks indicate significant differences from the control group (**, pϽ0.01). Diphen: diphenhydramine hydrochloride. See text for further details. the COX-inhibitory activities of P-HA were almost as strong as that of ibuprofen. Furthermore, acetylation of these hydroxylamines was shown to be slightly effective for increasing the COX-2 selectivity. That is, hydroxylamine compounds derived from oximes which have COX-1 inhibitory action but little inhibitory action of COX-2, 6) suppressed not only COX-1 but also COX-2. However, no selective inhibitory action against COX-2 was observed. Hydroxylamines (P-HA: IC 50 , 16.6 mM and M-HA: IC 50 , 198 mM) showed a 5-LOX inhibitory effect, while N,O-diacetylated hydroxylamines (P-HA-Ac and M-HA-Ac) had no effect (IC 50 Ͼ200 mM). The reference agent phenidone inhibited 5-LOX with an IC 50 of 2.74 mM.
On the other hand, no clear inhibitory effects of oxime (POx and M-Ox) and acetyl oxime (P-Ox-Ac and M-Ox-Ac) were noted on both type I and IV allergy and 5-LOX activity.
The present findings indicate that all tested hydroxylamines (P-HA and M-HA) and N,O-diacetyl hydroxylamines (P-HA-Ac and M-HA-Ac) can inhibit carrageenaninduced foot-pad swelling in mice, and suggest that the antiinflammatory action of these compounds is primarily due to inhibition of both COX-1 and COX-2 activities. It is remarkable that COX-2 inhibitory action appeared on conversion to hydroxylamines or N,O-diacetyl hydroxylamines from the corresponding oxime. Furthermore, P-HA and M-HA showed dual inhibitory actions of COXs and 5-LOX. P-HAAc suppressed the type I allergy reaction although more weakly than diphenhydramine hydrochloride. P-HA and M-HA significantly inhibited the type IV allergy reaction more strongly than phenidone did, but these compounds showed a lower 5-LOX inhibitory effect than phenidone. The anti-allergic action (type IV) of percutaneously applied P-HA and M-HA may be involved in the 5-LOX inhibitory effect of these compounds, at least in part, or their action may partly be due to their anti-inflammatory effects. The detailed mechanism of the anti-allergic effect remains unclear.
In conclusion, the present study suggests that hydroxylamine derivatives are promising candidates for anti-inflammatory and anti-allergic agents.
